about
Unsatisfactory gene transfer into bone-resorbing osteoclasts with liposomal transfection systemsPhenylketonuria: a review of current and future treatmentsPhysical methods for intracellular delivery: practical aspects from laboratory use to industrial-scale processing.Polymeric nucleic acid vehicles exploit active interorganelle trafficking mechanisms.Highly acetylated tubulin permits enhanced interactions with and trafficking of plasmids along microtubulesEnhanced core hydrophobicity, functionalization and cell penetration of polybasic nanomatrices.Autophagy induced by calcium phosphate precipitates targets damaged endosomes.DNA-encapsulated magnesium phosphate nanoparticles elicit both humoral and cellular immune responses in mice.RNA interference screen to identify pathways that enhance or reduce nonviral gene transfer during lipofection.Quantification of cytosolic plasmid DNA degradation using high-throughput sequencing: implications for gene deliveryEfficacy and mechanism of poloxamine-assisted polyplex transfectionTumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies.Formulations containing poly(lactide-co-glycolide) and plasmid DNA expression vectors.PLGA-based gene delivering nanoparticle enhance suppression effect of miRNA in HePG2 cells.Evaluating the intracellular stability and unpacking of DNA nanocomplexes by quantum dots-FRETState-of-the-art 2003 on PKU gene therapy.Approaches to enhance the efficacy of DNA vaccines.Transfection of brain capillary endothelial cells in primary culture with defined blood-brain barrier propertiesPlasmid DNA is internalized from the apical plasma membrane of the salivary gland epithelium in live animals.Intracellular trafficking of nucleic acidsTargeted polymers for gene delivery.Polymeric nanoparticles for gene delivery.Synthetic delivery systems for intravenous administration of nucleic acids.Nanovehicular intracellular delivery systems.Nanocapsule-delivered Sleeping Beauty mediates therapeutic Factor VIII expression in liver sinusoidal endothelial cells of hemophilia A mice.Novel cationic lipid that delivers siRNA and enhances therapeutic effect in lung cancer cells.Non-viral gene therapy for myocardial engineering.Retroviral vectors for gene therapy.From serendipity to mitochondria-targeted nanocarriers.Intradermal naked plasmid DNA immunization: mechanisms of action.Chemokine-based immunotherapy: delivery systems and combination therapies.Polymeric nanoparticles: potent vectors for vaccine delivery targeting cancer and infectious diseases.Technologies for the development of West Nile virus vaccines.Expression of scFv-Mel-Gal4 triple fusion protein as a targeted DNA-carrier in Escherichia Coli.Improvement of DNA vaccination by adjuvants and sophisticated delivery devices: vaccine-platforms for the battle against infectious diseases.Transporter molecules influence the gene expression in HeLa cells.Serum influence on in-vitro gene delivery using microbubble-assisted ultrasound.In vitro transfection mediated by dendrigraft poly(L-lysines): the effect of structure and molecule size.Lipopolyamine treatment increases the efficacy of intoxication with saporin and an anticancer saporin conjugate.Lipofection of insulin-producing RINm5F cells: methodological improvements.
P2860
Q24814004-7B4303C4-FC61-407E-A2B9-FC54BAF4630EQ26770291-FB2C246E-8D91-44D0-BD40-A9C19E0EC632Q30410734-84530A06-299C-4934-976B-366B1C5CEFA1Q30537017-75A62BAD-CED9-4866-AE18-C169216C1D1AQ30537126-AA02E5DC-FCAE-42F5-99E6-83229C5C526FQ33364166-2CF4CB7B-D040-4AA8-8B4A-60448ACC5F16Q33676253-211853A8-3120-468E-B011-F6875610456EQ33730191-A4038DEC-7926-4C14-88D3-407BCC28A089Q33789455-21F56984-8CC1-45F4-8ECB-F3B092EF7BE6Q33808484-E6DD490B-3F47-498F-9EE7-7B8DE54D68B5Q33858972-5FA270B6-81A5-47D0-90F3-269A73E64525Q34063131-FC6AAA0B-9A40-4DA9-BBAB-90006F58225CQ35207503-D3AD152C-8031-448F-9795-1B260DF70A42Q35537936-74C15E93-CB6B-4C68-9B0C-1B24C7EDB328Q35574622-C07F034E-7CE3-4EF6-A07B-98FF6B509793Q35631781-EDBFD0C8-CED2-4F81-A29D-CBCDA62BBB40Q35743279-4F51C22D-8762-41A7-BCB2-DA5A461C8FB3Q35923032-8C242B99-9337-4B37-ACC3-1403A34B3429Q36191185-8C06E030-A697-4974-BA5A-E75E08357C38Q36316640-0306DE0A-6AD4-4F8E-85D9-EB3BDCC033CEQ36316688-DA0DBD18-3575-4B90-B0D0-3CCA2A44EA6BQ36460846-61E7FABD-FFC4-4966-9BDA-E8EEF2724178Q36917917-0A7017D7-6711-4604-A556-2B6FFF620C41Q37058812-3D131ADA-F56F-4215-9C94-DB794C151DF4Q37241328-65B8E2F8-5AF8-4244-A64F-EDF7E2925961Q37390867-9A898820-7A64-436A-B416-2D10CBD833D6Q37671758-102026CB-C977-48CB-8BE6-1FF653983716Q37809064-8BB52B49-D2B1-4BF6-82FA-AAB844C9577DQ37915391-73230F89-72C7-4BB0-B7F3-EC3CDE66A6FBQ37919894-0305A81C-AE27-44B1-BF96-B4956D813F91Q38040509-43CA0CC3-6364-4516-A523-4F78D9A034A6Q38152851-8B29A14A-8162-470E-889C-AD1E304292D3Q38269151-BB7EE28C-417A-48B9-8FC2-BCE98D56979AQ38316948-28208912-06FE-405B-AAAB-D6B1BF18B3C2Q38342834-194EB7D9-24ED-4626-B537-03766D03BA61Q38510992-0A7EA712-2400-463A-BB88-1A528DFCF351Q38990017-CB5D8CC2-9365-45EA-9CE0-99DA587886D5Q39227454-0A945CC8-5BF7-4732-9D49-06D645259BD8Q40090541-1A42AAD6-E4BB-42E4-BF40-372A1889AFB0Q40110817-BD1FA05D-C78A-4679-9725-80C6A3B6CD24
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Intracellular barriers to non-viral gene transfer.
@ast
Intracellular barriers to non-viral gene transfer.
@en
Intracellular barriers to non-viral gene transfer.
@nl
type
label
Intracellular barriers to non-viral gene transfer.
@ast
Intracellular barriers to non-viral gene transfer.
@en
Intracellular barriers to non-viral gene transfer.
@nl
prefLabel
Intracellular barriers to non-viral gene transfer.
@ast
Intracellular barriers to non-viral gene transfer.
@en
Intracellular barriers to non-viral gene transfer.
@nl
P356
P1433
P1476
Intracellular barriers to non-viral gene transfer
@en
P2093
Delphine Lechardeur
P304
P356
10.2174/1566523024605609
P407
P577
2002-05-01T00:00:00Z